Pub Date : 2024-01-01DOI: 10.1177/23259582241258559
Aish Lovett, Rose Luder, Rebecca A Lillis, Isolde Butler, Julia Siren, Samuel Gomez, Kevin Kamis, Oluyomi Obafemi, Sarah E Rowan, Stefan Baral, Meredith E Clement
Uptake of PrEP remains suboptimal, especially in the Southern United States. Same-day or "Rapid PrEP Initiatives" (RPIs) in sexual health centers (SHCs) could facilitate access and overcome barriers to PrEP. We studied the adaptation of an RPI from Denver, Colorado to an SHC in New Orleans, Louisiana. Through focus group discussions (FGDs) with local SHC staff and PrEP providers, we developed a preliminary RPI model. In 5 FGDs with SHC clients referred for or taking PrEP, we gathered adaptation recommendations and feedback on model acceptability, feasibility, and utility. Providers and clients voiced unanimous support for the RPI. Clients favored the ease of same-day PrEP initiation and emphasized a desire for navigational support, financial counseling, and integration of PrEP care with their other clinical needs. Clients recommended that SHC providers discuss PrEP and HIV with all patients, regardless of providers' perception of risk. Next steps include small-scale implementation and evaluation.
{"title":"Client Perspectives on the Development of a Rapid PrEP Initiative at a Sexual Health Center in New Orleans, Louisiana.","authors":"Aish Lovett, Rose Luder, Rebecca A Lillis, Isolde Butler, Julia Siren, Samuel Gomez, Kevin Kamis, Oluyomi Obafemi, Sarah E Rowan, Stefan Baral, Meredith E Clement","doi":"10.1177/23259582241258559","DOIUrl":"10.1177/23259582241258559","url":null,"abstract":"<p><p>Uptake of PrEP remains suboptimal, especially in the Southern United States. Same-day or \"Rapid PrEP Initiatives\" (RPIs) in sexual health centers (SHCs) could facilitate access and overcome barriers to PrEP. We studied the adaptation of an RPI from Denver, Colorado to an SHC in New Orleans, Louisiana. Through focus group discussions (FGDs) with local SHC staff and PrEP providers, we developed a preliminary RPI model. In 5 FGDs with SHC clients referred for or taking PrEP, we gathered adaptation recommendations and feedback on model acceptability, feasibility, and utility. Providers and clients voiced unanimous support for the RPI. Clients favored the ease of same-day PrEP initiation and emphasized a desire for navigational support, financial counseling, and integration of PrEP care with their other clinical needs. Clients recommended that SHC providers discuss PrEP and HIV with all patients, regardless of providers' perception of risk. Next steps include small-scale implementation and evaluation.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241258559"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141262046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1177/23259582241293302
Adriam M Castilla-Encinas, Valeria Rocio Soto Salas, Hugo Alvarez-Delgado, Jhon E Bocanegra-Becerra, Paola L Rondan
Immune reconstitution inflammatory syndrome is a common manifestation in human immunodeficiency virus (HIV)-positive patients infected with tuberculosis (TB). One of the unusual complications of this condition is the development of psoas abscess. We describe a case of immune reconstitution inflammatory syndrome (IRIS) in a patient with disseminated TB under treatment, HIV-positive with a low CD4 cell count, complicated by bilateral psoas abscess. Our patient presented with fever, abdominal pain, and lymphadenopathy, typical symptoms of TB-IRIS. Diagnosis was confirmed by surgical drainage of the abscess of the right iliac psoas muscle with detection of acid-fast bacteria on Ziehl-Neelsen staining and negative culture of purulent discharge. Treatment with prednisone was started in addition to continuation of antituberculosis therapy and antiretroviral therapy.
免疫重建炎症综合征是人类免疫缺陷病毒(HIV)阳性结核病(TB)感染者的常见表现。该病症的异常并发症之一是腰肌脓肿。我们描述了一例正在接受治疗的播散性肺结核患者的免疫重建炎症综合征(IRIS)病例,该患者为 HIV 阳性,CD4 细胞计数较低,并伴有双侧腰肌脓肿。患者表现为发热、腹痛和淋巴结肿大,这些都是 TB-IRIS 的典型症状。通过手术引流右侧髂腰肌脓肿,在齐氏-奈尔森染色法检测到耐酸细菌,脓性分泌物培养阴性,确诊为肺结核-IRIS。除继续接受抗结核治疗和抗逆转录病毒治疗外,还开始使用泼尼松治疗。
{"title":"Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome Complicated by Large Bilateral Psoas Abscess: A Case Report.","authors":"Adriam M Castilla-Encinas, Valeria Rocio Soto Salas, Hugo Alvarez-Delgado, Jhon E Bocanegra-Becerra, Paola L Rondan","doi":"10.1177/23259582241293302","DOIUrl":"10.1177/23259582241293302","url":null,"abstract":"<p><p>Immune reconstitution inflammatory syndrome is a common manifestation in human immunodeficiency virus (HIV)-positive patients infected with tuberculosis (TB). One of the unusual complications of this condition is the development of psoas abscess. We describe a case of immune reconstitution inflammatory syndrome (IRIS) in a patient with disseminated TB under treatment, HIV-positive with a low CD4 cell count, complicated by bilateral psoas abscess. Our patient presented with fever, abdominal pain, and lymphadenopathy, typical symptoms of TB-IRIS. Diagnosis was confirmed by surgical drainage of the abscess of the right iliac psoas muscle with detection of acid-fast bacteria on Ziehl-Neelsen staining and negative culture of purulent discharge. Treatment with prednisone was started in addition to continuation of antituberculosis therapy and antiretroviral therapy.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241293302"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1177/23259582241282561
José M Zuniga
{"title":"U = U: A Catalyst for Ending AIDS as a Public Health Threat.","authors":"José M Zuniga","doi":"10.1177/23259582241282561","DOIUrl":"10.1177/23259582241282561","url":null,"abstract":"","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241282561"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406623/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1177/23259582241245228
William Pastor Smith
The primary goal of medical care during the pre-antiretroviral therapy (ART) era was to keep persons living with human immunodeficiency virus (HIV) alive, whereas since the advent of ART, the treatment objective has shifted to decreasing viral loads and infectiousness while increasing CD4+ T-cell counts and longevity. The health crisis, however, is in preventing and managing multimorbidity (ie, type 2 diabetes), which develops at a more accelerated or accentuated pace among aging persons living with HIV. Relative to the general population and age-matched uninfected adults, it may be more difficult for aging HIV-positive persons who also suffer from multimorbidity to improve negative lifestyle factors to the extent that their behaviors could support the prevention and management of diseases. With recommendations and a viable solution, this article explores the impact of negative lifestyle factors (ie, poor mental health, suboptimal nutrition, physical inactivity, alcohol use) on the health of aging individuals living with HIV.
在接受抗逆转录病毒疗法(ART)之前,医疗护理的主要目标是维持人类免疫缺陷病毒(HIV)感染者的生命,而自从抗逆转录病毒疗法出现以来,治疗目标已转向降低病毒载量和传染性,同时增加 CD4+ T 细胞数量和延长寿命。然而,健康危机在于预防和管理多病症(即 2 型糖尿病),这种疾病在高龄艾滋病病毒感染者中的发展速度更快或更明显。与普通人群和年龄匹配的未感染成年人相比,同时患有多病的老年艾滋病病毒感染者可能更难改善消极的生活方式因素,从而使他们的行为能够支持疾病的预防和管理。带着建议和可行的解决方案,本文探讨了消极生活方式因素(即精神健康状况差、营养不达标、缺乏运动、酗酒)对老年艾滋病病毒感染者健康的影响。
{"title":"Negative Lifestyle Factors Specific to Aging Persons Living with HIV and Multimorbidity.","authors":"William Pastor Smith","doi":"10.1177/23259582241245228","DOIUrl":"10.1177/23259582241245228","url":null,"abstract":"<p><p>The primary goal of medical care during the pre-antiretroviral therapy (ART) era was to keep persons living with human immunodeficiency virus (HIV) alive, whereas since the advent of ART, the treatment objective has shifted to decreasing viral loads and infectiousness while increasing CD4+ T-cell counts and longevity. The health crisis, however, is in preventing and managing multimorbidity (ie, type 2 diabetes), which develops at a more accelerated or accentuated pace among aging persons living with HIV. Relative to the general population and age-matched uninfected adults, it may be more difficult for aging HIV-positive persons who also suffer from multimorbidity to improve negative lifestyle factors to the extent that their behaviors could support the prevention and management of diseases. With recommendations and a viable solution, this article explores the impact of negative lifestyle factors (ie, poor mental health, suboptimal nutrition, physical inactivity, alcohol use) on the health of aging individuals living with HIV.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241245228"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11273731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1177/23259582241272007
Happy Alfayo Kyando, Novatus Tesha, Emmy Metta
Background: Uptake of HIV early infant diagnosis (HEID) among HIV-exposed infants is the key to timely initiation of Antiretroviral Treatment (ART). However, despite the availability of HEID services in Tanzania, its uptake is low. We aimed to determine predictors of mothers living with HIV' with HIV-exposed infants' uptake of HEID services in Iringa District, Tanzania.
Methods: A health facility-based cross-sectional study was conducted in Iringa District from May to June 2023. Mothers with HIV-exposed infants were recruited in the study through a multistage sampling technique and interviewed using pre-tested structured questions. Logistic regression analysis was employed to determine potential predictors of HEID uptake.
Results: A total of 309 mothers with HIV-exposed infants participated in the study. About 78.3% of the HIV-exposed infants had initial DNA PCR for HEID within 6 weeks of age and 86.1% within 8 weeks. Most mothers had high perceived benefits on uptake of HEID with a mean score of 4.3, high perceived self-efficacy with a mean score of 3.8 and 2.7 perceived risk of HIV infection on their HIV-exposed infants on the 5 scale Likert scale with 5 showing the highest perceived benefit, self-efficacy and risk. High perceived self-efficacy and being a businesswoman were the predictors of uptake of HEID. The odds of self-efficacy on the uptake of HEID by 2.4 times (aOR 2.4 95% CI 1.6-3.2) within 6 weeks of age and 1.9 (aOR 1.9 95% CI 1.3-2.7) within 8 weeks. The odds of being a businesswoman were 0.4 for 6 weeks and 0.3 for 8 weeks (aOR 0.4 95% CI 0.2-0.8) and (aOR 0.3 95% CI 0.1-0.8) respectively.
Conclusion: Over three-quarters of the HIV-exposed infants had initial DNA PCR for HEID testing as recommended. Perceived self-efficacy was the main factor influencing HEID uptake. These findings highlight the need for strengthening HIV-positive mother's self-efficacy for improved uptake of HEID services.
背景:在暴露于艾滋病毒的婴儿中开展艾滋病毒婴儿早期诊断(HEID)是及时开始抗逆转录病毒疗法(ART)的关键。然而,尽管坦桑尼亚提供婴儿艾滋病早期诊断服务,但接受率却很低。我们的目的是确定坦桑尼亚伊林加区感染艾滋病毒的母亲和暴露于艾滋病毒的婴儿接受 HEID 服务的预测因素:方法:2023 年 5 月至 6 月,我们在伊林加区开展了一项基于医疗机构的横断面研究。研究通过多阶段抽样技术招募了感染艾滋病毒的婴儿的母亲,并使用预先测试过的结构化问题对她们进行了访谈。研究采用了逻辑回归分析法,以确定接受 HEID 的潜在预测因素:共有 309 名感染艾滋病毒婴儿的母亲参与了研究。约 78.3% 的暴露于 HIV 的婴儿在出生后 6 周内进行了 HEID 初步 DNA PCR 检测,86.1% 的婴儿在出生后 8 周内进行了 DNA PCR 检测。在李克特五级量表中,大多数母亲对接受 HEID 的益处感知较高,平均得分为 4.3 分;对自我效能感知较高,平均得分为 3.8 分;对暴露于 HIV 的婴儿感染 HIV 的风险感知为 2.7 分,其中 5 分表示对益处、自我效能感和风险的感知最高。高自我效能感和女商人身份是预测接受 HEID 的因素。在 6 周内,自我效能感对接受 HEID 的几率增加了 2.4 倍(aOR 2.4 95% CI 1.6-3.2),在 8 周内增加了 1.9 倍(aOR 1.9 95% CI 1.3-2.7)。6周岁和8周岁女商人的几率分别为0.4(aOR 0.4 95% CI 0.2-0.8)和0.3(aOR 0.3 95% CI 0.1-0.8):超过四分之三的艾滋病病毒感染婴儿按照建议进行了初步的 DNA PCR HEID 检测。自我效能感是影响接受 HEID 检测的主要因素。这些研究结果突出表明,有必要加强 HIV 阳性母亲的自我效能感,以提高对 HEID 服务的接受程度。
{"title":"Predictors of Mothers Living with HIV Uptake of HIV Early Infant Diagnosis Services in Iringa District, Tanzania.","authors":"Happy Alfayo Kyando, Novatus Tesha, Emmy Metta","doi":"10.1177/23259582241272007","DOIUrl":"10.1177/23259582241272007","url":null,"abstract":"<p><strong>Background: </strong>Uptake of HIV early infant diagnosis (HEID) among HIV-exposed infants is the key to timely initiation of Antiretroviral Treatment (ART). However, despite the availability of HEID services in Tanzania, its uptake is low. We aimed to determine predictors of mothers living with HIV' with HIV-exposed infants' uptake of HEID services in Iringa District, Tanzania<b>.</b></p><p><strong>Methods: </strong>A health facility-based cross-sectional study was conducted in Iringa District from May to June 2023. Mothers with HIV-exposed infants were recruited in the study through a multistage sampling technique and interviewed using pre-tested structured questions. Logistic regression analysis was employed to determine potential predictors of HEID uptake.</p><p><strong>Results: </strong>A total of 309 mothers with HIV-exposed infants participated in the study. About 78.3% of the HIV-exposed infants had initial DNA PCR for HEID within 6 weeks of age and 86.1% within 8 weeks. Most mothers had high perceived benefits on uptake of HEID with a mean score of 4.3, high perceived self-efficacy with a mean score of 3.8 and 2.7 perceived risk of HIV infection on their HIV-exposed infants on the 5 scale Likert scale with 5 showing the highest perceived benefit, self-efficacy and risk. High perceived self-efficacy and being a businesswoman were the predictors of uptake of HEID. The odds of self-efficacy on the uptake of HEID by 2.4 times (aOR 2.4 95% CI 1.6-3.2) within 6 weeks of age and 1.9 (aOR 1.9 95% CI 1.3-2.7) within 8 weeks. The odds of being a businesswoman were 0.4 for 6 weeks and 0.3 for 8 weeks (aOR 0.4 95% CI 0.2-0.8) and (aOR 0.3 95% CI 0.1-0.8) respectively.</p><p><strong>Conclusion: </strong>Over three-quarters of the HIV-exposed infants had initial DNA PCR for HEID testing as recommended. Perceived self-efficacy was the main factor influencing HEID uptake. These findings highlight the need for strengthening HIV-positive mother's self-efficacy for improved uptake of HEID services.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241272007"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1177/23259582231188221
Peter A Newman, Suchon Tepjan, Kangwan Fongkaew, Pakorn Akkakanjanasupar, Jan Willem de Lind van Wijngaarden, Nuttapon Chonwanarat
Half of new HIV infections in Thailand are among young people, the majority of whom are young gay and other men who have sex with men (YMSM) and young transgender women (YTGW). Amid low pre-exposure prophylaxis (PrEP) coverage, we explored practice-based factors that impact PrEP engagement among YMSM and YTGW. In 2018, we conducted 4 focus group discussions with 20 YMSM and 5 YTGW, and 22 in-depth interviews (5 in 2022) with healthcare providers (HCPs), community-based organization (CBO)/nongovernmental organization (NGO) staff, and peer educators. The inclusion of PrEP in universal healthcare coverage, including YMSM and YTGW, is a substantial facilitator of PrEP use; however, systemic barriers at microsocial (lack of communication about PrEP from HCPs, teachers, parents), mesosocial (healthcare-service fragmentation, lack of PrEP-competent HCPs), and macrosocial levels (annual quotas on free HIV-testing, HIV- and sexual-stigma) constrain and disincentivize adolescents' engagement with PrEP. National scale-up of youth-friendly and LGBT-affirmative CBO/NGO clinics, HCP training, and tailored programs to support adolescents' adherence may promote PrEP engagement among YMSM and YTGW in Thailand.
{"title":"Multilevel Factors Impacting PrEP Engagement Among Young Gay Men and Young Transgender Women in Thailand: A Qualitative Analysis.","authors":"Peter A Newman, Suchon Tepjan, Kangwan Fongkaew, Pakorn Akkakanjanasupar, Jan Willem de Lind van Wijngaarden, Nuttapon Chonwanarat","doi":"10.1177/23259582231188221","DOIUrl":"https://doi.org/10.1177/23259582231188221","url":null,"abstract":"<p><p>Half of new HIV infections in Thailand are among young people, the majority of whom are young gay and other men who have sex with men (YMSM) and young transgender women (YTGW). Amid low pre-exposure prophylaxis (PrEP) coverage, we explored practice-based factors that impact PrEP engagement among YMSM and YTGW. In 2018, we conducted 4 focus group discussions with 20 YMSM and 5 YTGW, and 22 in-depth interviews (5 in 2022) with healthcare providers (HCPs), community-based organization (CBO)/nongovernmental organization (NGO) staff, and peer educators. The inclusion of PrEP in universal healthcare coverage, including YMSM and YTGW, is a substantial facilitator of PrEP use; however, systemic barriers at microsocial (lack of communication about PrEP from HCPs, teachers, parents), mesosocial (healthcare-service fragmentation, lack of PrEP-competent HCPs), and macrosocial levels (annual quotas on free HIV-testing, HIV- and sexual-stigma) constrain and disincentivize adolescents' engagement with PrEP. National scale-up of youth-friendly and LGBT-affirmative CBO/NGO clinics, HCP training, and tailored programs to support adolescents' adherence may promote PrEP engagement among YMSM and YTGW in Thailand.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"22 ","pages":"23259582231188221"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357065/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9850062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1177/23259582231203192
Anna J Dreyer, Sam Nightingale, Lena S Andersen, Jasper S Lee, Hetta Gouse, Steven A Safren, Conall O'Cleirigh, Kevin G F Thomas, John A Joska
Women with HIV (WWH) may be more vulnerable to cognitive impairment than men with HIV (MWH), which may be explained by the direct effects of HIV or by sociodemographic and psychiatric characteristics. We recruited 105 people with HIV (PWH; 76 women) with incomplete antiretroviral therapy adherence, comorbid major depressive disorder, and socioeconomically disadvantaged backgrounds. Participants completed neuropsychological testing and measures gathering sociodemographic, medical, and psychiatric information. We compared WWH and MWH cognitive performance using unadjusted and adjusted regressions, and within each respective group, we explored predictors of cognitive performance. Results showed no significant between-sex differences in cognitive performance, both globally and within domains. Fewer years of education (β = 0.94), illiteracy (β = 4.55), and greater food insecurity (β = -0.28) predicted lower cognitive performance in WWH but not MWH. We conclude that sex differences in PWH are likely due to sample characteristics representing broader inequalities, rather than true biological differences.
{"title":"Sex Differences in the Cognitive Performance of a South African Cohort of People With HIV and Comorbid Major Depressive Disorder.","authors":"Anna J Dreyer, Sam Nightingale, Lena S Andersen, Jasper S Lee, Hetta Gouse, Steven A Safren, Conall O'Cleirigh, Kevin G F Thomas, John A Joska","doi":"10.1177/23259582231203192","DOIUrl":"10.1177/23259582231203192","url":null,"abstract":"<p><p>Women with HIV (WWH) may be more vulnerable to cognitive impairment than men with HIV (MWH), which may be explained by the direct effects of HIV or by sociodemographic and psychiatric characteristics. We recruited 105 people with HIV (PWH; 76 women) with incomplete antiretroviral therapy adherence, comorbid major depressive disorder, and socioeconomically disadvantaged backgrounds. Participants completed neuropsychological testing and measures gathering sociodemographic, medical, and psychiatric information. We compared WWH and MWH cognitive performance using unadjusted and adjusted regressions, and within each respective group, we explored predictors of cognitive performance. Results showed no significant between-sex differences in cognitive performance, both globally and within domains. Fewer years of education (<i>β</i> = 0.94), illiteracy (<i>β</i> = 4.55), and greater food insecurity (<i>β </i>= -0.28) predicted lower cognitive performance in WWH but not MWH. We conclude that sex differences in PWH are likely due to sample characteristics representing broader inequalities, rather than true biological differences.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"22 ","pages":"23259582231203192"},"PeriodicalIF":2.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/43/7a/10.1177_23259582231203192.PMC10548808.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41134915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1177/23259582231186701
Daniel Oliver, David Mabirizi, Marisa Hast, Mary Grace Alwano, Chalilwe Chungu, Alphonce Kelemani, Chizoba Mbanefo, Jessica Gross, KaeAnne Parris, Stephanie Dowling, Adele Clark, Amanda Williams, Lauren Simao, Carolyn Amole, Kanchana Suggu, Jibrin Kama, Felton Mpasela, Leah Mtui, Vennie Nabitaka, Renée Saunders, Dhelia Williamson, Emilia D Rivadeneira, Susan Hrapcak, Sophie Nantume, Esther Nazziwa, Megumi Itoh, Edward Machage, Chibuzor Onyenuobi, Gloria Munthali, Anath Rwebembera, Mwiya Mwiya, Cordelia Katureebe, Akudo Ikpeazu, Thomas Fenn
The number of children newly infected with HIV dropped by 50%, from 320 000 in 2010 to 160 000 in 2021. Despite progress, ongoing gaps persist in diagnosis, continuity of care, and treatment optimization. In response, the United States President's Emergency Plan for AIDS Relief created the Faith-based Action for Scaling-Up Testing and Treatment for Epidemic Response (FASTER). Faith-based Action for Scaling-Up Testing and Treatment for Epidemic Response addressed gaps in countries with the highest unmet need by working with government to operationalize innovative interventions and ensure alignment with national priorities and with communities living with HIV to ensure the change was community-led. Between 2019 and 2021, FASTER's interventions were incorporated into national policies, absorbed by Ministries of Health, and taken up in subsequent awards and country operating plans. Continued effort is needed to sustain gains made during the FASTER initiative and to continue scaling evidence-based interventions to ensure that children and adolescents are not left behind in the global HIV response.
{"title":"A Model for Accelerating Access to Care and Treatment for Children and Adolescents Living with HIV in Nigeria, Tanzania, Uganda, and Zambia: The Faith-Based Action for Scaling-Up Testing and Treatment for the Epidemic Response (FASTER) Initiative.","authors":"Daniel Oliver, David Mabirizi, Marisa Hast, Mary Grace Alwano, Chalilwe Chungu, Alphonce Kelemani, Chizoba Mbanefo, Jessica Gross, KaeAnne Parris, Stephanie Dowling, Adele Clark, Amanda Williams, Lauren Simao, Carolyn Amole, Kanchana Suggu, Jibrin Kama, Felton Mpasela, Leah Mtui, Vennie Nabitaka, Renée Saunders, Dhelia Williamson, Emilia D Rivadeneira, Susan Hrapcak, Sophie Nantume, Esther Nazziwa, Megumi Itoh, Edward Machage, Chibuzor Onyenuobi, Gloria Munthali, Anath Rwebembera, Mwiya Mwiya, Cordelia Katureebe, Akudo Ikpeazu, Thomas Fenn","doi":"10.1177/23259582231186701","DOIUrl":"10.1177/23259582231186701","url":null,"abstract":"<p><p>The number of children newly infected with HIV dropped by 50%, from 320 000 in 2010 to 160 000 in 2021. Despite progress, ongoing gaps persist in diagnosis, continuity of care, and treatment optimization. In response, the United States President's Emergency Plan for AIDS Relief created the Faith-based Action for Scaling-Up Testing and Treatment for Epidemic Response (FASTER). Faith-based Action for Scaling-Up Testing and Treatment for Epidemic Response addressed gaps in countries with the highest unmet need by working with government to operationalize innovative interventions and ensure alignment with national priorities and with communities living with HIV to ensure the change was community-led. Between 2019 and 2021, FASTER's interventions were incorporated into national policies, absorbed by Ministries of Health, and taken up in subsequent awards and country operating plans. Continued effort is needed to sustain gains made during the FASTER initiative and to continue scaling evidence-based interventions to ensure that children and adolescents are not left behind in the global HIV response.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"22 ","pages":"23259582231186701"},"PeriodicalIF":2.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a0/02/10.1177_23259582231186701.PMC10388624.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9909796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1177/23259582231161029
Amelia M Stanton, Benjamin D Hornstein, Nicholas Musinguzi, Brett Dolotina, Catherine Orrell, Gideon Amanyire, Stephen Asiimwe, Anna Cross, Christina Psaros, David Bangsberg, Judith A Hahn, Jessica E Haberer, Lynn T Matthews
Identifying factors associated with alcohol use changes during pregnancy is important for developing interventions for people with HIV (PWH). Pregnant PWH (n = 202) initiating antiretroviral therapy in Uganda and South Africa completed two assessments, 6 months apart (T1, T2). Categories were derived based on AUDIT-C scores: "no use" (AUDIT-C = 0 at T1 and T2), "new use" (AUDIT-C = 0 at T1, >0 at T2), "quit" (AUDIT-C > 0 at T1, =0 at T2), and "continued use" (AUDIT-C > 0, T1 and T2). Factors associated with these categories were assessed. Most participants had "no use" (68%), followed by "continued use" (12%), "quit" (11%), and "new use" (9%). Cohabitating with a partner was associated with lower relative risk of "continued use." Borderline significant associations between food insecurity and higher risk of "new use" and between stigma and reduced likelihood of "quitting" also emerged. Alcohol use interventions that address partnership, food security, and stigma could benefit pregnant and postpartum PWH.
{"title":"Factors Associated With Changes in Alcohol Use During Pregnancy and the Postpartum Transition Among People With HIV in South Africa and Uganda.","authors":"Amelia M Stanton, Benjamin D Hornstein, Nicholas Musinguzi, Brett Dolotina, Catherine Orrell, Gideon Amanyire, Stephen Asiimwe, Anna Cross, Christina Psaros, David Bangsberg, Judith A Hahn, Jessica E Haberer, Lynn T Matthews","doi":"10.1177/23259582231161029","DOIUrl":"https://doi.org/10.1177/23259582231161029","url":null,"abstract":"<p><p>Identifying factors associated with alcohol use changes during pregnancy is important for developing interventions for people with HIV (PWH). Pregnant PWH (n = 202) initiating antiretroviral therapy in Uganda and South Africa completed two assessments, 6 months apart (T1, T2). Categories were derived based on AUDIT-C scores: \"no use\" (AUDIT-C = 0 at T1 and T2), \"new use\" (AUDIT-C = 0 at T1, >0 at T2), \"quit\" (AUDIT-C > 0 at T1, =0 at T2), and \"continued use\" (AUDIT-C > 0, T1 and T2). Factors associated with these categories were assessed. Most participants had \"no use\" (68%), followed by \"continued use\" (12%), \"quit\" (11%), and \"new use\" (9%). Cohabitating with a partner was associated with lower relative risk of \"continued use.\" Borderline significant associations between food insecurity and higher risk of \"new use\" and between stigma and reduced likelihood of \"quitting\" also emerged. Alcohol use interventions that address partnership, food security, and stigma could benefit pregnant and postpartum PWH.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"22 ","pages":"23259582231161029"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034296/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9587331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1177/23259582231170732
Emma Gillette, Violet Naanyu, Winstone Nyandiko, Ashley Chory, Michael Scanlon, Josephine Aluoch, Hillary Koros, Celestine Ashimosi, Whitney Beigon, Dennis Munyoro, Janet Lidweye, Jack Nyagaya, Allison DeLong, Rami Kantor, Rachel Vreeman
Introduction: HIV stigma affects medication adherence, psychosocial outcomes, and clinical management for youth living with HIV (YLWH). We explored the impact of HIV stigma on research participation, to inform the ethical engagement of this vulnerable group. Methods: We interviewed 40 YLWH, 20 caregivers, and 39 subject matter experts (SMEs); transcripts were analyzed by HK and EG, with emerging themes confirmed by JA and AC. Results: All categories of participants identified the impacts of stigma on YLWH research participation, suggesting implementing privacy protections, considering recruitment locations carefully, and developing supportive relationships with YLWH. SMEs suggested that YLWH experience uniquely high risks from stigma due to the compounding effects of developmental challenges and transitionary life period. Accidental HIV disclosure and subsequent stigma were identified as a risk of research participation; some viewed the creation of community through research as a benefit. Conclusion: Participants provided insights into stigma-related considerations for research with YLWH, which may guide engagement protocols.
{"title":"HIV-Related Stigma Shapes Research Participation for Youth Living With HIV in Kenya.","authors":"Emma Gillette, Violet Naanyu, Winstone Nyandiko, Ashley Chory, Michael Scanlon, Josephine Aluoch, Hillary Koros, Celestine Ashimosi, Whitney Beigon, Dennis Munyoro, Janet Lidweye, Jack Nyagaya, Allison DeLong, Rami Kantor, Rachel Vreeman","doi":"10.1177/23259582231170732","DOIUrl":"https://doi.org/10.1177/23259582231170732","url":null,"abstract":"<p><p><b>Introduction:</b> HIV stigma affects medication adherence, psychosocial outcomes, and clinical management for youth living with HIV (YLWH). We explored the impact of HIV stigma on research participation, to inform the ethical engagement of this vulnerable group. <b>Methods:</b> We interviewed 40 YLWH, 20 caregivers, and 39 subject matter experts (SMEs); transcripts were analyzed by HK and EG, with emerging themes confirmed by JA and AC. <b>Results:</b> All categories of participants identified the impacts of stigma on YLWH research participation, suggesting implementing privacy protections, considering recruitment locations carefully, and developing supportive relationships with YLWH. SMEs suggested that YLWH experience uniquely high risks from stigma due to the compounding effects of developmental challenges and transitionary life period. Accidental HIV disclosure and subsequent stigma were identified as a risk of research participation; some viewed the creation of community through research as a benefit. <b>Conclusion:</b> Participants provided insights into stigma-related considerations for research with YLWH, which may guide engagement protocols.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"22 ","pages":"23259582231170732"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/76/4c/10.1177_23259582231170732.PMC10141251.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10061692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}